inPractice® - Prognosis of Hodgkin’s Lymphoma

Non–AIDS-Defining Cancers

Authors: David Aboulafia, MD; Liron Pantanowitz, MD (More Info)
Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
Last Reviewed: 12/12/16 (What's New)

Summary

Rates of CR, OS, and DFS now approach those of general population^{[Montoto 2012; Hentrich 2012; Jacobson 2012]}
Response to ART has emerged as an independent prognostic factor for improved response, longer survival, and DFS^{[Ribera 2002; Hentrich 2006]}
- All patients with HIV-related Hodgkin's lymphoma should therefore receive ART^{[Jacobson 2012]}

Action required

Login now to access all of your entitled content
or
View additional options to gain access to this content

Keywords: Cancer